By Christian Moess Laursen GSK said Wednesday that it has received authorization for its respiratory syncytial virus vaccine Arexvy from the European Commission, the executive body of the. | June 7, 2023
GSK - ENTERED INTO SECONDARY BLOCK TRADE AGREEMENT WITH BOFA SECURITIES UNDER WHICH BOFA SECURITIES APPOINTED AS SOLE GLOBAL COORDINATOR OF OFFERING . | May 11, 2023
GSK plc: GSK ANNOUNCES INTENTION TO SELL SHARES IN HALEON ANNOUNCES THAT IT INTENDS TO SELL UP TO 240M ORDINARY
SHARES IN
HALEON, EQUIVALENT TO UP TO 2.5% OF HALEON S. | May 11, 2023
GSK PLC on Tuesday announced it has agreed to acquire Quebec-based late-stage biopharmaceutical firm Bellus Health Inc for a total equity value of USD2.0 billion.
The USD14.75 per-share price of the. | April 18, 2023